Literature DB >> 4744026

The molecular basis of the action of chloroquine in porphyria cutanea tarda.

P L Scholnick, J Epstein, H S Marver.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4744026     DOI： 10.1111/1523-1747.ep12676478

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  8 in total

1.  Discoid lupus erythematosus and porphyria cutanea tarda.

Authors:  F M O'Reilly; S O'Loughlin; G M Murphy
Journal:  J R Soc Med       Date:  1996-09       Impact factor: 5.344

2.  Differential uptake of chloroquine by human keratinocytes and melanocytes in culture.

Authors:  G Sjölin-Forsberg; B Berne; M Johansson; M J Olsson; O Rollman
Journal:  Arch Dermatol Res       Date:  1996-04       Impact factor: 3.017

3.  Hepatotoxic reaction to chloroquine phosphate in a patient with previously unrecognized porphyria cutanea tarda.

Authors:  A C Liu
Journal:  West J Med       Date:  1995-06

4.  [Influence of chloroquine on the hexachlorobenzene-induced porphyria. Investigations in the skin, liver, and urine (author's transl)].

Authors:  W Vizethum; K Bolsen; K Simon; K Weber; G Goerz
Journal:  Arch Dermatol Res       Date:  1980       Impact factor: 3.017

5.  Low-dose hydroxychloroquine is as effective as phlebotomy in treatment of patients with porphyria cutanea tarda.

Authors:  Ashwani K Singal; Csilla Kormos-Hallberg; Chul Lee; Vaithamanithi M Sadagoparamanujam; James J Grady; Daniel H Freeman; Karl E Anderson
Journal:  Clin Gastroenterol Hepatol       Date:  2012-09-14       Impact factor: 11.382

6.  Influence of chloroquine on the porphyrin metabolism.

Authors:  G Goerz; K Bolsen; H Merk
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

Review 7.  Natural and semisynthetic candidate molecules for COVID-19 prophylaxis and treatment.

Authors:  Andrei Biţă; Ion Romulus Scorei; Laurenţiu Mogoantă; Cornelia Bejenaru; George Dan Mogoşanu; Ludovic Everard Bejenaru
Journal:  Rom J Morphol Embryol       Date:  2020 Apr-Jun       Impact factor: 1.033

Review 8.  Repurposing Chloroquine Against Multiple Diseases With Special Attention to SARS-CoV-2 and Associated Toxicity.

Authors:  Siya Kamat; Madhuree Kumari
Journal:  Front Pharmacol       Date:  2021-04-12       Impact factor: 5.810
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.